Question 1

Has Vicki Baker received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,934 in general payments to Vicki Baker across 69 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Vicki Baker did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Vicki Baker come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
GSK	1	$1,840
Novartis	8	$122
Astellas Pharma US Inc	2	$118
AstraZeneca(2 entities)	8	$98
Teva Pharmaceuticals USA, Inc.	5	$92
Amgen	5	$70
Genentech USA, Inc.	5	$68
Pfizer	4	$65
Tersera Therapeutics LLC	3	$52
E.r. Squibb & Sons, L.L.C.	3	$39
Daiichi Sankyo Inc.	2	$38
Heron Therapeutics, Inc.	2	$32
Boston Scientific	2	$32
Tesaro, Inc.	2	$30
Lilly USA, LLC	2	$28
Bristol Myers Squibb	2	$27
Gilead	2	$25
Taiho Oncology, Inc.	1	$19
Sanofi	1	$16
Incyte Corporation	1	$16
Boehringer Ingelheim	1	$16
EMD Serono, Inc.	1	$15
Eisai Inc.	1	$14
Kyowa Kirin, Inc.	1	$14
Merck	1	$13
Regeneron Healthcare Solutions, Inc.	1	$13
Ipsen Biopharmaceuticals, Inc	1	$12
Pharmacyclics LLC, An Abbvie Company	1	$12

Vicki Baker

Payments from drug & device makers

Who reported the general payments

How this compares

Other hematology & oncology in Tulsa